fda approves generic glp 1 First of Once-Daily GLP-1 Injection to Lower Blood Sugar in Patients with Type 2 Diabetes The prescribing information for the generic liraglutide injection approved today… GLP-1 Safety Check - National

We report an unusual case of diabetic ketoalkalosis, a mixed acid-base disorder, in a 57-year-old female patient with insulin-dependent T2DM following a switch to Mounjaro (tirzepatide)

![Figure][1] Graphical Abstract: ### Competing Interest Statement The FR + FMG laboratory receives funding from AstraZeneca, Eli Lilly and LGM for unrelated research and FMG consults for Kallyope (New York)

David Kessler says the new weight-loss drugs are a powerful tool to fight obesity

Injection-site reactions and worsening of pre-existing diabetic retinopathy are also relevant clinical concerns

Novo Nordisk is putting down up to US$362m to tap into Ascendis TransCon technology for treatments in metabolic and cardiovascular diseases